Shuttle pharmaceuticals inc stock
WebApr 7, 2024 · Shuttle Pharmaceuticals Holdings Inc’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. There are not analysts providing consensus earnings estimates for the current fiscal year. Shuttle Pharmaceuticals Holdings Inc does not currently pay a dividend. WebApr 10, 2024 · A high-level overview of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Shuttle pharmaceuticals inc stock
Did you know?
WebDec 29, 2024 · Shuttle Pharmaceuticals Holdings (NASDAQ: SHPH) is owned by 0.98% institutional shareholders, 72.32% Shuttle Pharmaceuticals Holdings insiders, and 26.70% retail investors. Anatoly Dritschilo is the largest individual Shuttle Pharmaceuticals Holdings shareholder, owning 7.49M shares representing 54.88% of the company.
WebMar 17, 2024 · Shuttle Pharmaceuticals Stock (NASDAQ:SHPH), Analyst Ratings, Price Targets, Predictions. Analysts publish ratings and price targets on most stocks. WebShuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. ... Stock prices can fluctuate wildly, and analyst ratings are provided to help self-directed traders evaluate securities.
WebMar 3, 2024 · Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. WebFeb 17, 2024 · Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
WebGet the latest Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock news and headlines to help you in your trading and investing decisions.
WebShuttle Pharmaceuticals Provides Fiscal Year 2024 Corporate Update. Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today provided a corporate update in connection with … highland games in paWebMar 11, 2024 · Complete Shuttle Pharmaceuticals Holdings Inc. stock information by Barron's. View real-time SHPH stock price and news, along with industry-best analysis. highland games in michiganWebMar 30, 2024 · Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, ... Shuttle Pharmaceuticals Holdings, Inc. lowest stock price was $1.18 and its highest was $126.26 in the past 12 months. highland games in new hampshireWebFind the latest Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock quote, history, news and other vital information to help you with your stock trading and investing. highland games kiltWebMar 9, 2024 · Game Changing Potential. Shuttle Pharmaceuticals is developing first-in-class therapies that are designed to cure cancer and improve the outcomes of patients receiving radiation therapy. Our focus is on products with unique properties to sensitize cancer cells, protect normal tissues and monitor clinical responses to treatment. highland games las vegas 2023WebView the latest Shuttle Pharmaceuticals Holdings Inc. (SHPH) stock price, news, historical charts, analyst ratings and financial information from WSJ. how is epsom salt usedWebShuttle Pharmaceuticals Holdings Inc Stock. Add to Watchlist. Overview. Earnings Dividend Ownership. $1.39-0.06 (-4.14%) Updated Apr 6, 2024. ... Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. highland games in pleasanton ca